Trial Profile
Phase I trial of CCX 507 in adult volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 15 Dec 2014
Price :
$35
*
At a glance
- Drugs CCX 507 (Primary)
- Indications Inflammatory bowel diseases
- Focus Adverse reactions; Pharmacokinetics
- Sponsors ChemoCentryx
- 12 Aug 2013 Positive safety data have been presented, according to a ChemoCentryx media release.
- 22 May 2013 Status changed from recruiting to active, no longer recruiting, according to a ChemoCentryx media release.
- 13 Mar 2013 Results are expected to be available in the second half of 2013, according to a ChemoCentryx media release.